Citation Impact
Citing Papers
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
Gut microbiota dysbiosis contributes to the development of hypertension
2017
Oxygen and the regulation of gene expression in wounds
2003
Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development
2007
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
2011 Standout
Nitrite‐derived nitric oxide: a possible mediator of ‘acidic–metabolic’ vasodilation
2001
The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics
2008 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management
2007 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Structure and function of the blood–brain barrier
2009 Standout
Creatine Transport in Cultured Cells of Rat and Mouse Brain
1989
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair
2004
Current concepts in the pathogenesis of urea cycle disorders
2010
Coordinated regulation of myeloid cells by tumours
2012 Standout
Inconsistency of Reported Uremic Toxin Concentrations
2007
Hepatic Dysfunction Caused by Consumption of a High-Fat Diet
2017
Murine Models of Renal Disease: Possibilities and Problems in Studies Using Mutant Mice
2000
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
GABAA Receptor Channels
1994 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Is it time to reevaluate methyl balance in humans?
2006
Chronic kidney disease
2011 Standout
Cyclooxygenase and 5‐lipoxygenase pathways in the vessel wall: Role in atherosclerosis
2004
Nitric oxide deficiency in chronic kidney disease
2007
Acute kidney injury
2019 Standout
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
2002
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Cardiorenal Syndrome
2008 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients
1997
Uremia
2007
Kidney–brain crosstalk in the acute and chronic setting
2015
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes
2007
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Comparative properties of arginases
1996
Comparative metabonomics of differential hydrazine toxicity in the rat and mouse
2004
Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney
2000
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Recent advances in arginine metabolism
2003
Neurological complications in renal failure: a review
2004
Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation
2010
Pericytes regulate the blood–brain barrier
2010 StandoutNature
Metabolomic profiling of uremic solutes in CKD patients
2010
Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques
1999
Plasma, Urinary, and Erythrocyte Concentrations of Guanidino Compounds in Patients with Chronic Renal Failure
1999
A Bench to Bedside View of Uremic Toxins
2008
Chronic Kidney Disease
2016 Standout
Increased Erythrocytes By-Products of Arginine Catabolism Are Associated with Hyperglycemia and Could Be Involved in the Pathogenesis of Type 2 Diabetes Mellitus
2013
Morris water maze: procedures for assessing spatial and related forms of learning and memory
2006 Standout
Global metabolic profiling procedures for urine using UPLC–MS
2010 Standout
Applications of the Ninhydrin Reaction for Analysis of Amino Acids, Peptides, and Proteins to Agricultural and Biomedical Sciences
2004 Standout
Applications of the Morris water maze in the study of learning and memory
2001 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
2003
Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway
2004
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Maturation of the enteric mucosal innate immune system during the postnatal period
2014
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Physiology and pharmacological role of the blood-brain barrier.
2009
Effects of Probiotic Lactobacillus Paracasei Treatment on the Host Gut Tissue Metabolic Profiles Probed via Magic-Angle-Spinning NMR Spectroscopy
2007
Mechanisms of Diabetic Complications
2013 Standout
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
2019
Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes
2004
Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery
2015 StandoutNobel
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
2004
Metabolomics for Investigating Physiological and Pathophysiological Processes
2019
Creatine Kinase Gene Mutation in a Patient with Muscle Creatine Kinase Deficiency
2001 StandoutNobel
Arginine metabolism: nitric oxide and beyond
1998 Standout
Antiinflammatory Properties of HDL
2004 Standout
Creatine and Creatinine Metabolism
2000 Standout
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis
1992 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Bart Marescau being referenced
Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis
1997
Effect of ammonium acetate-induced hyperammonemia on metabolism of guanidino compounds
1991
Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals
1992
Dual effects of oxidized low-density lipoprotein on ommune-stimulated nitric oxide and prostaglandin release in macrophages
1996
Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid development,,
2002
Biochemical and histopathological changes in nephrectomized mice
1998
Overexpression of Arginase Alters Circulating and Tissue Amino Acids and Guanidino Compounds and Affects Neuromotor Behavior in Mice
2001
GSA: behavioral, histological, electrophysiological and neurochemical effects
2005
Behavioural Deficits During the Acute Phase of Mild Renal Failure in Mice
1999
Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status
2007
Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia
2010
Endogenous guanidino compounds as uremic neurotoxins
2001
Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants
1992
Complex Compartmental Behavior of Small Water-Soluble Uremic Retention Solutes: Evaluation by Direct Measurements in Plasma and Erythrocytes
2007
l-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome
2012
Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency
1987
AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse
2013
Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans
2004
Kinetic behavior of urea is different from that of other water-soluble compounds: The case of the guanidino compounds
2005
Effect of NaCN on currents evoked by uremic retention solutes in dissociated mouse neurons
2004
Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiency
1996
Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy
1995
Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice
1992
N G,N G-Dimethylarginine and N G,N'G-dimethylarginine in renal insufficiency
2000
Guanidino Compound Metabolism in Arginine-Free DietInduced Hyperammonemia
1991
Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis
2009
Serum Guanidino Compound Levels in Uremic Pediatric Patients Treated with Hemodialysis or Continuous Cycle Peritoneal Dialysis
1995
Oxidized Lipoproteins Suppress Nitric Oxide Synthase in Macrophages:Study of Glucocorticoid Receptor Involvement
1994
Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism
1997
Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia
2007
Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins
2003
Serum Guanidino Compound Levels and Clearances in Uremic Patients Treated with Continuous Ambulatory Peritoneal Dialysis
1990
Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice
2001
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse
2013
Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency
1997
Hyperargininemia, epilepsy and the metabolism of guanidino compounds.
1989
Guanidino compounds in uraemic dialysed patients
1986
Comparative Study of Guanidino Compounds in Serum and Brain of Mouse, Rat, Rabbit, and Man
1986
Increased Sensitivity to Vecuronium in Patients with Chronic Renal Failure
1993
Clinical and pathophysiological aspects of neurological complications in renal failure.
1992
Effect of Endotoxemia on Plasma and Tissue Levels of Nitric Oxide Metabolites and Guanidino Compounds
1997
Renal handling of guanidino compounds in rat and rabbit.
1997
N G , N G -Dimethylarginine and N G , N ' G -dimethylarginine in renal insufficiency
2000
Molecular genetic study of human arginase deficiency.
1992
Serum Guanidino Compound Levels and the Influence of a Single Hemodialysis in Uremic Patients Undergoing Maintenance Hemodialysis
1987
Measurement of arginine transport in human erythrocytes using their intrinsic arginase activity: implications for the treatment of familial hyperargininemia
1982